Article
Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium.
Pharmacogenomics - 1 Jul 2017
Farzan Niloufar, Vijverberg Susanne J, Andiappan Anand K, Arianto Lambang, Berce Vojko, Blanca-López Natalia, Bisgaard Hans, Bønnelykke Klaus, Burchard Esteban G, Campo Paloma, Canino Glorisa, Carleton Bruce, Celedón Juan C, Chew Fook Tim, Chiang Wen Chin, Cloutier Michelle M, Daley Denis, Den Dekker Herman T, Dijk F Nicole, Duijts Liesbeth, Flores Carlos, Forno Erick, Hawcutt Daniel B, Hernandez-Pacheco Natalia, de Jongste Johan C, Kabesch Michael, Koppelman Gerard H, Manolopoulos Vangelis G, Melén Erik, Mukhopadhyay Somnath, Nilsson Sara, Palmer Colin N, Pino-Yanes Maria, Pirmohamed Munir, Potočnik Uros, Raaijmakers Jan A, Repnik Katja, Schieck Maximilian, Sio Yang Yie, Smyth Rosalind L, Szalai Csaba, Tantisira Kelan G, Turner Steve, van der Schee Marc P, Verhamme Katia M, Maitland-van der Zee Anke H
Abstract excerpt
AIM: International collaboration is needed to enable large-scale pharmacogenomics studies in childhood asthma. Here, we describe the design of the Pharmacogenomics in Childhood Asthma (PiCA) consortium. MATERIALS & METHODS: Investigators of each study participating in PiCA provided data on the study characteristics by answering an online questionnaire. RESULTS: A total of 21 studies, including 14,227...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
